What will Codex DNA's stock price reach in the next year?
On average, they expect Codex DNA's stock price to reach $23.19 in the next year. This suggests a possible upside of 219.4% from the stock's current price.
Where can I buy dnay shares?
Shares of DNAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What does dnay stand for?
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the fourth quarter and year ended December 31, 2021 and provided financial guidance for 2022.
Is DNAY a Good Stock to buy?
Codex DNA has 452.49% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How do I buy DNA stocks?
How to buy shares in Codex DNACompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
What is the best DNA stock?
Illumina. Illumina is the industry leader in using short-read sequencing technology, which breaks DNA into short segments to aid in analysis for genetic research, testing, and medical treatment. ... Pacific Biosciences of California. ... Exact Sciences. ... Invitae. ... Fulgent Genetics. ... Intellia Therapeutics. ... CRISPR Therapeutics.
Which company is the king of genetic sequencing?
IlluminaAbout Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.
Should I buy or sell Codex DNA stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Codex DNA in the last twelve months. There are currently 3 buy ratings for...
What is Codex DNA's stock price forecast for 2022?
3 analysts have issued 1 year price targets for Codex DNA's shares. Their forecasts range from $8.00 to $23.00. On average, they anticipate Codex D...
How has Codex DNA's stock price performed in 2022?
Codex DNA's stock was trading at $10.80 on January 1st, 2022. Since then, DNAY shares have decreased by 67.7% and is now trading at $3.49. View th...
When is Codex DNA's next earnings date?
Codex DNA is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022. View our earnings forecast for Codex DNA .
How were Codex DNA's earnings last quarter?
Codex DNA, Inc. (NASDAQ:DNAY) announced its earnings results on Wednesday, May, 11th. The company reported ($0.45) earnings per share (EPS) for the...
What guidance has Codex DNA issued on next quarter's earnings?
Codex DNA updated its FY 2022 earnings guidance on Tuesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period....
Who are Codex DNA's key executives?
Codex DNA's management team includes the following people: Dr. Todd R. Nelson MBA , Ph.D., Pres, COO, CEO & Director (Age 55, Pay $876.78k) Ms....
Who are some of Codex DNA's key competitors?
Some companies that are related to Codex DNA include Akoya Biosciences (AKYA) , Berkeley Lights (BLI) , EyePoint Pharmaceuticals (EYPT) , Singu...
When did Codex DNA IPO?
(DNAY) raised $100 million in an initial public offering (IPO) on Friday, June 18th 2021. The company issued 6,700,000 shares at $14.00-$16.00 per...
Headlines
Codex DNA (NASDAQ:DNAY) Frequently Asked Questions
Thinking about buying stock in Tilray, Avinger, Reliance Global, BioCryst Pharmaceuticals, or Codex DNA?
